The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with clonazepam.


The risk or severity of adverse effects can be increased when propantheline is combined with pirenzepine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Halobetasol.


The risk or severity of adverse effects can be increased when mecamylamine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with quetiapine.


The risk or severity of adverse effects can be increased when Perospirone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when mirtazapine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when scopolamine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when pancuronium is combined with oxycodone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with danazol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when cilnidipine is combined with epoprostenol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with clomipramine.


The risk or severity of adverse effects can be increased when carprofen is combined with betamethasone.


The risk or severity of adverse effects can be increased when methysergide is combined with rapamycin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with dantrolene.


The risk or severity of adverse effects can be increased when imipramine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when imipramine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when imipramine is combined with doxazosin.


The risk or severity of adverse effects can be increased when scopolamine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Isoconazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when meprobamate is combined with dibucaine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when tiapride is combined with promethazine.


The risk or severity of adverse effects can be increased when tiapride is combined with clonazepam.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with furazolidone.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Perospirone.


The risk or severity of adverse effects can be increased when equilin is combined with memantine.


The risk or severity of adverse effects can be increased when equilin is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with procarbazine.


The risk or severity of adverse effects can be increased when leflunomide is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when protriptyline is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with betamethasone.


The risk or severity of adverse effects can be increased when Talniflumate is combined with fenoprofen.


The risk or severity of adverse effects can be increased when aspirin is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when docetaxel is combined with pipobroman.


The risk or severity of adverse effects can be increased when enflurane is combined with Difenoxin.


The risk or severity of adverse effects can be increased when indapamide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when thiothixene is combined with Tolcapone.


The risk or severity of adverse effects can be increased when thiothixene is combined with amitriptyline.


The risk or severity of adverse effects can be increased when trazodone is combined with clomipramine.


The risk or severity of adverse effects can be increased when trazodone is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when fenbufen is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Propacetamol.


The risk or severity of adverse effects can be increased when tretinoin is combined with triamterene.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when suprofen is combined with loteprednol.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Rotigotine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with diazepam.


The risk or severity of adverse effects can be increased when aspirin is combined with halcinonide.


The risk or severity of adverse effects can be increased when irbesartan is combined with Bretylium.


The risk or severity of adverse effects can be increased when Cangrelor is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when propofol is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when cilnidipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with malathion.


The risk or severity of adverse effects can be increased when betamethasone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when propofol is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Asenapine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when ramipril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when rivastigmine is combined with metoclopramide.


The risk or severity of adverse effects can be increased when ramipril is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Milnacipran is combined with loxapine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Apremilast.


The risk or severity of adverse effects can be increased when cilnidipine is combined with nicardipine.


The risk or severity of adverse effects can be increased when butalbital is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when valsartan is combined with Icatibant.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with malathion.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Flupentixol.


The risk or severity of adverse effects can be increased when thiothixene is combined with Normethadone.


The risk or severity of adverse effects can be increased when apomorphine is combined with spironolactone.


The risk or severity of adverse effects can be increased when resveratrol is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Dothiepin.


The risk or severity of adverse effects can be increased when isradipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when risperidone is combined with trazodone.


The risk or severity of adverse effects can be increased when Isoconazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with prazosin.


The risk or severity of adverse effects can be increased when procyclidine is combined with methadone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with felbamate.


The risk or severity of adverse effects can be increased when indomethacin is combined with fluocinonide.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with penbutolol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with dyclonine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with desoximetasone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with clonazepam.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when enflurane is combined with tiagabine.


The risk or severity of adverse effects can be increased when olanzapine is combined with topiramate.


The risk or severity of adverse effects can be increased when enflurane is combined with ondansetron.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with amisulpride.


The risk or severity of adverse effects can be increased when haloperidol is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when enflurane is combined with zonisamide.


The risk or severity of adverse effects can be increased when oxazepam is combined with quazepam.


The risk or severity of adverse effects can be increased when prednisone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Cis-mdp is combined with Deferasirox.


The risk or severity of adverse effects can be increased when dicyclomine is combined with tolterodine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Etomidate is combined with clemastine.


The risk or severity of adverse effects can be increased when Naftifine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when secobarbital is combined with estazolam.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with baclofen.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with fluocinonide.


The risk or severity of adverse effects can be increased when morphine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when secobarbital is combined with duloxetine.


The risk or severity of adverse effects can be increased when rivastigmine is combined with nicotine.


The risk or severity of adverse effects can be increased when rivastigmine is combined with Cevimeline.


The risk or severity of adverse effects can be increased when QUINETHAZONE is combined with digitoxin.


The risk or severity of adverse effects can be increased when butorphanol is combined with brotizolam.


The risk or severity of adverse effects can be increased when quetiapine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when benzocaine is combined with butamben.


The risk or severity of adverse effects can be increased when valsartan is combined with furosemide.


The risk or severity of adverse effects can be increased when valsartan is combined with tizanidine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with melphalan.


The risk or severity of adverse effects can be increased when valsartan is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Tramadol is combined with halothane.


The risk or severity of adverse effects can be increased when quazepam is combined with Pramocaine.


The risk or severity of adverse effects can be increased when oxazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ketamine is combined with Etomidate.


The risk or severity of adverse effects can be increased when mesalamine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when MELPERONE is combined with felbamate.


The risk or severity of adverse effects can be increased when ketamine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with nifedipine.


The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Riociguat.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with papaverine.


The risk or severity of adverse effects can be increased when trandolapril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when betaxolol is combined with isradipine.


The risk or severity of adverse effects can be increased when betaxolol is combined with Olmesartan.


The risk or severity of adverse effects can be increased when Ramelteon is combined with flunarizine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Pirlindole.


The risk or severity of adverse effects can be increased when secobarbital is combined with paroxetine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with prazepam.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when topiramate is combined with clidinium.


The risk or severity of adverse effects can be increased when valsartan is combined with Olsalazine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with formestane.


The risk or severity of adverse effects can be increased when bupivacaine is combined with felbamate.


The risk or severity of adverse effects can be increased when trandolapril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when gabapentin is combined with brotizolam.


The risk or severity of adverse effects can be increased when orphenadrine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Butethal is combined with fexofenadine.


The risk or severity of adverse effects can be increased when sulindac is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when fludiazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Metixene.


The risk or severity of adverse effects can be increased when propranolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when triazolam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when benztropine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when reserpine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Conivaptan is combined with metolazone.


The risk or severity of adverse effects can be increased when azelastine is combined with diflorasone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with protriptyline.


The risk or severity of adverse effects can be increased when pergolide is combined with chloramphenicol.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when pergolide is combined with teniposide.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with carisoprodol.


The risk or severity of adverse effects can be increased when methoxamine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when captopril is combined with quetiapine.


The risk or severity of adverse effects can be increased when lidocaine is combined with procaine.


The risk or severity of adverse effects can be increased when flurazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when flurazepam is combined with procaine.


The risk or severity of adverse effects can be increased when pergolide is combined with lansoprazole.


The risk or severity of adverse effects can be increased when Torasemide is combined with paromomycin.


The risk or severity of adverse effects can be increased when procarbazine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when procarbazine is combined with zotepine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with enoxacin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with budesonide.


The risk or severity of adverse effects can be increased when trazodone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Halazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when morniflumate is combined with nabumetone.


The risk or severity of adverse effects can be increased when morniflumate is combined with ketorolac.


The risk or severity of adverse effects can be increased when clomipramine is combined with timolol.


The risk or severity of adverse effects can be increased when morniflumate is combined with tenoxicam.


The risk or severity of adverse effects can be increased when nitric oxide is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Lacidipine is combined with propofol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when prazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Nebivolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when pergolide is combined with Tramadol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with spironolactone.


The risk or severity of adverse effects can be increased when ramipril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when desipramine is combined with dobutamine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with losartan.


The risk or severity of adverse effects can be increased when Sacubitril is combined with thioridazine.


The risk or severity of adverse effects can be increased when bumetanide is combined with quetiapine.


The risk or severity of adverse effects can be increased when butabarbital is combined with promazine.


The risk or severity of adverse effects can be increased when butabarbital is combined with methocarbamol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with ketamine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with baclofen.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with quetiapine.


The risk or severity of adverse effects can be increased when metaraminol is combined with methoxamine.


The risk or severity of adverse effects can be increased when Nabilone is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when baclofen is combined with tiagabine.


The risk or severity of adverse effects can be increased when amoxapine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when triazolam is combined with efavirenz.


The risk or severity of adverse effects can be increased when amitriptyline is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when fludiazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when amoxapine is combined with maprotiline.


The risk or severity of adverse effects can be increased when baclofen is combined with zonisamide.


The risk or severity of adverse effects can be increased when prazosin is combined with lisinopril.


The risk or severity of adverse effects can be increased when isoflurane is combined with atenolol.


The risk or severity of adverse effects can be increased when prazosin is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when ILOPROST is combined with propofol.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when reserpine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with lisinopril.


The risk or severity of adverse effects can be increased when docetaxel is combined with suramin.


The risk or severity of adverse effects can be increased when Icatibant is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when propofol is combined with efavirenz.


The risk or severity of adverse effects can be increased when Icatibant is combined with Droxicam.


The risk or severity of adverse effects can be increased when Vecuronium is combined with oxycodone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Fospropofol.


The risk or severity of adverse effects can be increased when diclofenac is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when captopril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with butalbital.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with tizanidine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when butorphanol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with prazepam.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with quazepam.


The risk or severity of adverse effects can be increased when sevoflurane is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with chlormezanone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Desloratadine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with phenytoin.


The risk or severity of adverse effects can be increased when fenbufen is combined with desoximetasone.


The risk or severity of adverse effects can be increased when flurazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Articaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Articaine is combined with zotepine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Pizotifen.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with bezafibrate.


The risk or severity of adverse effects can be increased when captopril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when meprobamate is combined with butorphanol.


The risk or severity of adverse effects can be increased when etodolac is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with thiothixene.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with potassium ion.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with ketoprofen.


The risk or severity of adverse effects can be increased when amobarbital is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Retigabine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Metixene.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with furazolidone.


The risk or severity of adverse effects can be increased when fexofenadine is combined with flunarizine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with clonidine.


The risk or severity of adverse effects can be increased when estazolam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when quazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ketamine is combined with maprotiline.


The risk or severity of adverse effects can be increased when ropinirole is combined with mecamylamine.


The risk or severity of adverse effects can be increased when ketamine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when trazodone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when oxycodone is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when ramipril is combined with tolmetin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when Salsalate is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when fexofenadine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when alprazolam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when diazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when flurazepam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when flurazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when diazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when amobarbital is combined with clemastine.


The risk or severity of adverse effects can be increased when amobarbital is combined with lidocaine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with spironolactone.


The risk or severity of adverse effects can be increased when alprazolam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Etomidate is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when amobarbital is combined with venlafaxine.


The risk or severity of adverse effects can be increased when barnidipine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with pentazocine.


The risk or severity of adverse effects can be increased when biperiden is combined with HEROIN.


The risk or severity of adverse effects can be increased when selegiline is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with CYPROTERONE ACETATE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with meclizine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with felbamate.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Naloxegol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when tizanidine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ketorolac is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with diflorasone.


The risk or severity of adverse effects can be increased when ketorolac is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Phenelzine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with ibuprofen.


The risk or severity of adverse effects can be increased when amoxapine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when gabapentin is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with DESONIDE.


The risk or severity of adverse effects can be increased when gabapentin is combined with clonazepam.


The risk or severity of adverse effects can be increased when gabapentin is combined with promethazine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with triprolidine.


The risk or severity of adverse effects can be increased when mesalamine is combined with Clobetasone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with methylphenidate.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with rasagiline.


The risk or severity of adverse effects can be increased when quetiapine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with suprofen.


The risk or severity of adverse effects can be increased when methysergide is combined with Netupitant.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when antipyrine is combined with flunisolide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with furosemide.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when triamcinolone is combined with mefloquine.


The risk or severity of adverse effects can be increased when halothane is combined with trandolapril.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Apremilast is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when tretinoin is combined with Olmesartan.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with loratadine.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with Escitalopram.


The risk or severity of adverse effects can be increased when nabumetone is combined with sulindac.


The risk or severity of adverse effects can be increased when valsartan is combined with diflunisal.


The risk or severity of adverse effects can be increased when etodolac is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with scopolamine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when ethyl icosapentate is combined with salicylic acid.


The risk or severity of adverse effects can be increased when etodolac is combined with prednisone.


The risk or severity of adverse effects can be increased when baclofen is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Propiverine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with levodopa.


The risk or severity of adverse effects can be increased when thiamylal is combined with Perospirone.


The risk or severity of adverse effects can be increased when zopiclone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when enflurane is combined with butalbital.


The risk or severity of adverse effects can be increased when benzocaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when Tramadol is combined with atorvastatin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with baclofen.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Perospirone.


The risk or severity of adverse effects can be increased when triprolidine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when midazolam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when propofol is combined with brotizolam.


The risk or severity of adverse effects can be increased when lorazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when hydromorphone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with nimesulide.


The risk or severity of adverse effects can be increased when Dapagliflozin is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when midazolam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with indapamide.


The risk or severity of adverse effects can be increased when oxprenolol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with zotepine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when perphenazine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when celecoxib is combined with budesonide.


The risk or severity of adverse effects can be increased when thiopental is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when thiopental is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when duloxetine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when sulpiride is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when pentazocine is combined with bumetanide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Drospirenone.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with proparacaine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with triprolidine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with nimesulide.


The risk or severity of adverse effects can be increased when estrone is combined with donepezil.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Tramadol.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when clorazepate is combined with duloxetine.


The risk or severity of adverse effects can be increased when clorazepate is combined with fluoxetine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with vinblastine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when carbamazepine is combined with pargyline.


The risk or severity of adverse effects can be increased when baclofen is combined with clonidine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with thiothixene.


The risk or severity of adverse effects can be increased when thalidomide is combined with indapamide.


The risk or severity of adverse effects can be increased when topiramate is combined with doxepin.


The risk or severity of adverse effects can be increased when ondansetron is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when nicergoline is combined with propofol.


The risk or severity of adverse effects can be increased when nicergoline is combined with acetazolamide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when lidocaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when cabergoline is combined with doxepin.


The risk or severity of adverse effects can be increased when morphine is combined with Normethadone.


The risk or severity of adverse effects can be increased when methysergide is combined with Boceprevir.


The risk or severity of adverse effects can be increased when alprazolam is combined with flurazepam.


The risk or severity of adverse effects can be increased when thioridazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when rizatriptan is combined with risperidone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Treprostinil is combined with tenoxicam.


The risk or severity of adverse effects can be increased when amphotericin b is combined with rasagiline.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with quinidine.


The risk or severity of adverse effects can be increased when alclofenac is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when meprobamate is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Treprostinil is combined with nabumetone.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Treprostinil is combined with ketorolac.


The risk or severity of adverse effects can be increased when thioridazine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with nifedipine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with papaverine.


The risk or severity of adverse effects can be increased when thioridazine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when thioridazine is combined with thiopental.


The risk or severity of adverse effects can be increased when cabergoline is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with papaverine.


The risk or severity of adverse effects can be increased when cabergoline is combined with nitric oxide.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with diazoxide.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with topiramate.


The risk or severity of adverse effects can be increased when oxycodone is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with prilocaine.


The risk or severity of adverse effects can be increased when thioridazine is combined with estazolam.


The risk or severity of adverse effects can be increased when amitriptyline is combined with loratadine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Articaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Flupentixol is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when furazolidone is combined with dobutamine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Eplerenone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with methazolamide.


The risk or severity of adverse effects can be increased when Efonidipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when minoxidil is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when morphine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when morphine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when morphine is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Boceprevir.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when amobarbital is combined with ondansetron.


The risk or severity of adverse effects can be increased when benzocaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when amobarbital is combined with tiagabine.


The risk or severity of adverse effects can be increased when amobarbital is combined with cocaine.


The risk or severity of adverse effects can be increased when benzocaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when amobarbital is combined with zonisamide.


The risk or severity of adverse effects can be increased when nimesulide is combined with budesonide.


The risk or severity of adverse effects can be increased when meprobamate is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Rufinamide is combined with brotizolam.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when nimesulide is combined with pravastatin.


The risk or severity of adverse effects can be increased when linezolid is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when linezolid is combined with thiothixene.


The risk or severity of adverse effects can be increased when diclofenac is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when linezolid is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Perospirone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with nimodipine.


The risk or severity of adverse effects can be increased when enalapril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when chlormezanone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when butabarbital is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when quazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when betamethasone is combined with malathion.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when nitrazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when budesonide is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with furosemide.


The risk or severity of adverse effects can be increased when budesonide is combined with malathion.


The risk or severity of adverse effects can be increased when labetalol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Tramadol is combined with proparacaine.


The risk or severity of adverse effects can be increased when gabapentin is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when quazepam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when meprobamate is combined with pimozide.


The risk or severity of adverse effects can be increased when fenoldopam is combined with pramipexole.


The risk or severity of adverse effects can be increased when oxaprozin is combined with medrysone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when METAXALONE is combined with maprotiline.


The risk or severity of adverse effects can be increased when quazepam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when tetracaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Drospirenone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Sacubitril is combined with methazolamide.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with sulpiride.


The risk or severity of adverse effects can be increased when Risedronic acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when thioridazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when topiramate is combined with tiagabine.


The risk or severity of adverse effects can be increased when linezolid is combined with sulpiride.


The risk or severity of adverse effects can be increased when imipramine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when D-mannitol is combined with methyldopa.


The risk or severity of adverse effects can be increased when imipramine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when metoprolol is combined with quinapril.


The risk or severity of adverse effects can be increased when Telithromycin is combined with toremifene.


The risk or severity of adverse effects can be increased when butabarbital is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with furosemide.


The risk or severity of adverse effects can be increased when Naftifine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Asenapine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when pargyline is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with zotepine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Articaine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Escitalopram.


The risk or severity of adverse effects can be increased when methocarbamol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when propoxyphene is combined with efavirenz.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Alvimopan.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with triflupromazine.


The risk or severity of adverse effects can be increased when brimonidine is combined with paroxetine.


The risk or severity of adverse effects can be increased when ropinirole is combined with spironolactone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with procaine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with ritonavir.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with haloperidol.


The risk or severity of adverse effects can be increased when oxprenolol is combined with sotalol.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with acemetacin.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with vindesine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Bexarotene.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Efonidipine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with mitomycin C.


The risk or severity of adverse effects can be increased when fosinopril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when Artemether is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Artemether is combined with Benidipine.


The risk or severity of adverse effects can be increased when Artemether is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Artemether is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Artemether is combined with Efonidipine.


The risk or severity of adverse effects can be increased when buprenorphine is combined with moclobemide.


The risk or severity of adverse effects can be increased when Pramocaine is combined with butalbital.


The risk or severity of adverse effects can be increased when zaleplon is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when amifostine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when epoprostenol is combined with nifedipine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with papaverine.


The risk or severity of adverse effects can be increased when clemastine is combined with scopolamine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with levorphanol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with perphenazine.


The risk or severity of adverse effects can be increased when Apremilast is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when tiagabine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when methyldopa is combined with papaverine.


The risk or severity of adverse effects can be increased when methyldopa is combined with nifedipine.


The risk or severity of adverse effects can be increased when olanzapine is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when felodipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when methysergide is combined with midazolam.


The risk or severity of adverse effects can be increased when imipramine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when valsartan is combined with Torasemide.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with codeine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when buspirone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when mefloquine is combined with nicotine.


The risk or severity of adverse effects can be increased when mefloquine is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when reserpine is combined with Bretylium.


The risk or severity of adverse effects can be increased when imipramine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when reserpine is combined with halothane.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with budesonide.


The risk or severity of adverse effects can be increased when sulindac is combined with halcinonide.


The risk or severity of adverse effects can be increased when methysergide is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when Paliperidone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when methysergide is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when lovastatin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when tropicamide is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when pergolide is combined with paramethasone.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with physostigmine.


The risk or severity of adverse effects can be increased when chloroquine is combined with nimesulide.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with fenbufen.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when carisoprodol is combined with flunarizine.


The risk or severity of adverse effects can be increased when haloperidol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when azelastine is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when amoxapine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Etomidate is combined with clonazepam.


The risk or severity of adverse effects can be increased when midazolam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Pipamperone is combined with imipramine.


The risk or severity of adverse effects can be increased when promazine is combined with Etomidate.


The risk or severity of adverse effects can be increased when atenolol is combined with methyldopa.


The risk or severity of adverse effects can be increased when atenolol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with betamethasone.


The risk or severity of adverse effects can be increased when brimonidine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with METAXALONE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with brotizolam.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with fenbufen.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when minoxidil is combined with clonidine.


The risk or severity of adverse effects can be increased when nimodipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when chloroquine is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Carbetocin.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with thiothixene.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when metolazone is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when celiprolol is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with halcinonide.


The risk or severity of adverse effects can be increased when Telaprevir is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with difluprednate.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when tiapride is combined with tiagabine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with clomipramine.


The risk or severity of adverse effects can be increased when triprolidine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when promethazine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when tiapride is combined with zonisamide.


The risk or severity of adverse effects can be increased when paramethasone is combined with ambenonium.


The risk or severity of adverse effects can be increased when loratadine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with ethosuximide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with potassium ion.


The risk or severity of adverse effects can be increased when HEROIN is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when methoxamine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Tramadol is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when loxapine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when amphotericin b is combined with barnidipine.


The risk or severity of adverse effects can be increased when haloperidol is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when haloperidol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when thalidomide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when butalbital is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with diflunisal.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Eprosartan.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with malathion.


The risk or severity of adverse effects can be increased when morphine is combined with triazolam.


The risk or severity of adverse effects can be increased when prilocaine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when nicergoline is combined with Palbociclib.


The risk or severity of adverse effects can be increased when triprolidine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with promethazine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with trimipramine.


The risk or severity of adverse effects can be increased when promethazine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with estramustine.


The risk or severity of adverse effects can be increased when promethazine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when butorphanol is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when naratriptan is combined with triflupromazine.


The risk or severity of adverse effects can be increased when naratriptan is combined with haloperidol.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with hydralazine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when Isoconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with dicumarol.


The risk or severity of adverse effects can be increased when prazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when HEROIN is combined with Drospirenone.


The risk or severity of adverse effects can be increased when butalbital is combined with Milnacipran.


The risk or severity of adverse effects can be increased when fosinopril is combined with suprofen.


The risk or severity of adverse effects can be increased when amitriptyline is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Pirlindole is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with methscopolamine.


The risk or severity of adverse effects can be increased when temazepam is combined with butamben.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with ethosuximide.


The risk or severity of adverse effects can be increased when citalopram is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when oxaprozin is combined with prednisone.


The risk or severity of adverse effects can be increased when ethotoin is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when bromocriptine is combined with bifonazole.


The risk or severity of adverse effects can be increased when oxaprozin is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with spironolactone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with medrysone.


The risk or severity of adverse effects can be increased when Icatibant is combined with DESONIDE.


The risk or severity of adverse effects can be increased when tiapride is combined with topiramate.


The risk or severity of adverse effects can be increased when mepivacaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with glutethimide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when benztropine is combined with ethopropazine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with sulpiride.


The risk or severity of adverse effects can be increased when triamterene is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with efavirenz.


The risk or severity of adverse effects can be increased when prazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when haloperidol is combined with propoxyphene.


The risk or severity of adverse effects can be increased when cilazapril is combined with diclofenac.


The risk or severity of adverse effects can be increased when metolazone is combined with nicardipine.


The risk or severity of adverse effects can be increased when efavirenz is combined with dantrolene.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Asenapine.


The risk or severity of adverse effects can be increased when tioconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when BOPINDOLOL is combined with pilocarpine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when clotrimazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when lisinopril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when pentobarbital is combined with procaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when cabergoline is combined with mirtazapine.


The risk or severity of adverse effects can be increased when quetiapine is combined with procaine.


The risk or severity of adverse effects can be increased when promazine is combined with zonisamide.


The risk or severity of adverse effects can be increased when metolazone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when prazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Cangrelor is combined with mesalamine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with citalopram.


The risk or severity of adverse effects can be increased when chloroquine is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Naftifine.


The risk or severity of adverse effects can be increased when dorzolamide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when buspirone is combined with oxazepam.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Normethadone.


The risk or severity of adverse effects can be increased when Fidaxomicin is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when trazodone is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when trazodone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when naratriptan is combined with Flupentixol.


The risk or severity of adverse effects can be increased when labetalol is combined with metaproterenol.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with enoxacin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Clevidipine.


The risk or severity of adverse effects can be increased when naratriptan is combined with Cariprazine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with amisulpride.


The risk or severity of adverse effects can be increased when procaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with dantrolene.


The risk or severity of adverse effects can be increased when methylergonovine is combined with raloxifene.


The risk or severity of adverse effects can be increased when THYMOL is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with warfarin.


The risk or severity of adverse effects can be increased when ondansetron is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when triprolidine is combined with zonisamide.


The risk or severity of adverse effects can be increased when ondansetron is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when ethopropazine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when prednisone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Perampanel is combined with Escitalopram.


The risk or severity of adverse effects can be increased when carprofen is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when cilnidipine is combined with selegiline.


The risk or severity of adverse effects can be increased when carprofen is combined with prednisone.


The risk or severity of adverse effects can be increased when propofol is combined with minoxidil.


The risk or severity of adverse effects can be increased when ondansetron is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when haloperidol is combined with tetracaine.


The risk or severity of adverse effects can be increased when Dothiepin is combined with isoproterenol.


The risk or severity of adverse effects can be increased when propofol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when timolol is combined with losartan.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with manidipine.


The risk or severity of adverse effects can be increased when propofol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with betaxolol.


The risk or severity of adverse effects can be increased when trandolapril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when trandolapril is combined with fenbufen.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with spironolactone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Efonidipine is combined with fluvastatin.


The risk or severity of adverse effects can be increased when chloroquine is combined with ibuprofen.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with triprolidine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with felbamate.


The risk or severity of adverse effects can be increased when fenoldopam is combined with tretinoin.


The risk or severity of adverse effects can be increased when fenoldopam is combined with isoflurane.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when cilostazol is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Sacubitril is combined with sulindac.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with loteprednol.


The risk or severity of adverse effects can be increased when loxapine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when loxapine is combined with oxazepam.


The risk or severity of adverse effects can be increased when estazolam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when prilocaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with desipramine.


The risk or severity of adverse effects can be increased when dibucaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when risperidone is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when risperidone is combined with benzocaine.


The risk or severity of adverse effects can be increased when loxapine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when apomorphine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with nadolol.


The risk or severity of adverse effects can be increased when apomorphine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with desoximetasone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Riociguat.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when ergocalciferol is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when etodolac is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Normethadone is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Droxicam is combined with dexamethasone.


The risk or severity of adverse effects can be increased when nicergoline is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when benzocaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when benazepril is combined with epirizole.


The risk or severity of adverse effects can be increased when fosinopril is combined with captopril.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when ketoprofen is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when sevoflurane is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with ethosuximide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with doxazosin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Deferasirox.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when sevoflurane is combined with thiopental.


The risk or severity of adverse effects can be increased when sevoflurane is combined with labetalol.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with perphenazine.


The risk or severity of adverse effects can be increased when oxycodone is combined with flunarizine.


The risk or severity of adverse effects can be increased when scopolamine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when benzocaine is combined with Butethal.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when desoximetasone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when propofol is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when benzocaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Salsalate is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with budesonide.


The risk or severity of adverse effects can be increased when nitric oxide is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when paroxetine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Butethal is combined with loratadine.


The risk or severity of adverse effects can be increased when Butethal is combined with imipramine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with clonazepam.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with butamben.


The risk or severity of adverse effects can be increased when miconazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when oxymorphone is combined with clonidine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when griseofulvin is combined with nimesulide.


The risk or severity of adverse effects can be increased when Tavaborole is combined with nimodipine.


The risk or severity of adverse effects can be increased when Asenapine is combined with zotepine.


The risk or severity of adverse effects can be increased when Asenapine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when morniflumate is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when penbutolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when haloprogin is combined with felodipine.


The risk or severity of adverse effects can be increased when temazepam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Pramocaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when zaleplon is combined with trimipramine.


The risk or severity of adverse effects can be increased when apomorphine is combined with enalapril.


The risk or severity of adverse effects can be increased when fluoxetine is combined with Tianeptine.


The risk or severity of adverse effects can be increased when zaleplon is combined with procaine.


The risk or severity of adverse effects can be increased when labetalol is combined with felodipine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when D-mannitol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when labetalol is combined with irbesartan.


The risk or severity of adverse effects can be increased when isoflurane is combined with trandolapril.


The risk or severity of adverse effects can be increased when clorazepate is combined with sertraline.


The risk or severity of adverse effects can be increased when tizanidine is combined with indapamide.


The risk or severity of adverse effects can be increased when pentobarbital is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with flunisolide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Bendamustine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with clonidine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with clidinium.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with methocarbamol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with alclometasone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when clorazepate is combined with topiramate.


The risk or severity of adverse effects can be increased when dibucaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when dibucaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when loxapine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Droxicam is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when meclizine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when phentolamine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with indapamide.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Droxicam is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when butabarbital is combined with Asenapine.


The risk or severity of adverse effects can be increased when linezolid is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with niflumic acid.


The risk or severity of adverse effects can be increased when alprazolam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when acemetacin is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Phenelzine is combined with amisulpride.


The risk or severity of adverse effects can be increased when acemetacin is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with promethazine.


The risk or severity of adverse effects can be increased when butabarbital is combined with levodopa.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with Milnacipran.


The risk or severity of adverse effects can be increased when azelastine is combined with antipyrine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with dibucaine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when valsartan is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when valsartan is combined with atenolol.


The risk or severity of adverse effects can be increased when lidocaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with thiothixene.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with penbutolol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Quinupristin.